Biocon Limited (BIOCON)
NSEINR 368.551.67%
Price Chart
Key Statistics
Market Cap
INR 483.77B
P/E Ratio
42.90
Revenue (TTM)
INR 152.62B
Volume
7.39M
52W High
INR 404.70
52W Low
INR 291.00
Dividend Yield
0.14%
Beta
0.22
Technicals
50-Day MA
338.551
200-Day MA
344.8203
52 Week High
404.7
52 Week Low
291
About BIOCON
Biocon Limited, together with its subsidiaries, engages in the manufacture and sale of biotechnology products and research services in India, Brazil, Singapore, and internationally. It operates throug.
Employees
N/A
Headquarters
Bengaluru, India
CEO
Dr. Kiran Mazumdar-Shaw B.Sc (Hons), B.Sc.
Latest News
Bridging The Void: How Biocon Biologics Sees The Future Of Biosimilars In Europe - insights.citeline.com
16 hours ago • Google News
Health Canada approves Biocon's Yesafili, biosimilar to Eylea - Ophthalmology Times
Yesterday • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg